Skip to main content


Icon Legend
Presentation Icons
CE credit available
CE credit available
Pharmacology credit available
Pharmacology credit available
Poster session
Poster session

Full Schedule

Full Schedule

  • Friday, November 10, 2023
  • 6:30 AM – 7:45 AM ET
    Breakfast Activity/Non-CE-Accredited Satellite Symposium
    Janssen Oncology invites you to learn more about a treatment for adult patients with RRMM who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody
    Janssen: Pharmaceutical Companies of Johnson & Johnson

    Seating available on first-come, first-served basis
  • 6:30 AM – 7:45 AM ET
    Breakfast Activity/Non-CE-Accredited Satellite Symposium: Exelixis Clinical Product Overview for Advanced Practice Providers
    Exelixis

    Seating available on first-come, first-served basis
  • 6:30 AM – 7:45 AM ET
    Breakfast Activity/Non-CE-Accredited Satellite Symposium: Supporting Patients With HR+/HER2- mBC Throughout Their Treatment Journey
    Pfizer Oncology

    Seating available on first-come, first served basis
  • 6:30 AM – 7:45 AM ET
    Breakfast Activity/Non-CE-Accredited Satellite Symposium: Treatment Options for Patients with Unresectable or Metastatic Melanoma​
    Bristol Myers Squibb

    Seating available on first-come, first-served basis
  • 6:30 AM – 6:00 PM ET
    Registration
  • 7:00 AM – 8:00 AM ET
    Exhibit Hall Open & Continental Breakfast
  • 8:00 AM – 8:10 AM ET
    Welcome & Opening Remarks
  • 8:10 AM – 9:15 AM ET
    Opening Panel Discussion
    Advanced Practitioners in Hematology and Oncology: A Call to Action
  • 9:30 AM – 10:15 AM ET
    Optimizing the Care of Patients with Colorectal Cancer in Clinical Practice
  • 9:30 AM – 10:15 AM ET
    The Evolving Landscape of Frontline Therapy in Chronic Lymphocytic Leukemia
  • 10:15 AM – 11:15 AM ET
    Exhibit Hall Open & Refreshment Break
  • 10:15 AM – 6:15 PM ET
    Braindate
  • 10:30 AM – 11:00 AM ET
    APSHO Committee Meet & Greet: Awards & Recognition Committee
  • 10:30 AM – 11:00 AM ET
    Exhibit Hall Presentation: An Advancement in Frontline DLBCL
    Genentech
  • 10:30 AM – 11:00 AM ET
    Exhibit Hall Presentation: Cosela: A Multilineage Myeloprotection Therapy
    G1 Therapeutics
  • 10:30 AM – 11:30 AM ET
    Exhibit Hall Presentation: Relapsed or Refractory Multiple Myeloma: A Case-based Presentation
    Sanofi
  • 11:15 AM – 12:15 PM ET
    Advancing Precision-Targeted Treatment for Patients with Metastatic Non-Small Cell Lung Cancer
  • 11:15 AM – 12:15 PM ET
    Cardio-Oncology Considerations in Patients With Cancer
  • 12:15 PM – 1:45 PM ET
    Exhibit Hall Open & Lunch
  • 12:15 PM – 1:45 PM ET
    Lunch Activity/Non-CE-Accredited Satellite Symposium: A Collaborative Approach to Deciding When to Intervene With Jakafi® (ruxolitinib) For Adults With Polycythemia Vera Who Have Had an Inadequate Response to Hydroxyurea
    Incyte

    Seating available on first-come, first served basis
  • 12:15 PM – 1:45 PM ET
    Lunch Activity/Non-CE-Accredited Satellite Symposium: PADCEV® (enfortumab vedotin-ejfv): Use as A Single Agent or In Combination With a PD⁠-⁠1 Inhibitor - 081-1005-PM
    Seagen

    Seating available on first-come, first-served basis
  • 12:15 PM – 1:45 PM ET
    Lunch Activity/Non-CE-Accredited Satellite Symposium: The Role of APPs in Maximizing Patient Outcomes with DARZALEX® and DARZALEX® FASPRO® +Rd in Patients with Newly Diagnosed, Transplant-Ineligible Multiple Myeloma.
    Janssen Oncology part of the Pharmaceutical Companies of Johnson & Johnson

    Seating available on first-come, first-served basis
  • 12:15 PM – 1:45 PM ET
    Lunch Activity/Non-CE-Accredited Satellite Symposium: Treatment Options for Patients with Resectable and Metastatic Non-Small Cell Lung Cancer​
    Bristol Myers Squibb

    Seating available on first-come, first-served basis
  • 12:30 PM – 1:00 PM ET
    APSHO Committee Meet & Greet: Communications Committee
  • 1:15 PM – 1:45 PM ET
    APSHO Committee Meet & Greet: Diversity, Equity, & Inclusion Committee (DEI)
  • 1:45 PM – 2:45 PM ET
    Keynote Address: We the Patients
  • 2:45 PM – 3:45 PM ET
    Exhibit Hall Open & Refreshment Break
  • 2:45 PM – 3:45 PM ET
    Moderated Posters: Clinical Posters, Industry Encore Posters, & APSHO Patient Perspective Posters
  • 3:00 PM – 3:30 PM ET
    APSHO Committee Meet & Greet: Education Committee
  • 3:00 PM – 3:30 PM ET
    Exhibit Hall Presentation
    Bispecific Antibodies in DLBCL: Navigating the Evolving Treatment Landscape
    AbbVie and Genmab
  • 3:00 PM – 3:30 PM ET
    Exhibit Hall Presentation: Diagnostic Approach and Considerations in Patients with Hemolytic Anemia
    Agios Pharmaceuticals
  • 3:00 PM – 3:30 PM ET
    Exhibit Hall Presentation: Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor.
    Eli Lilly and Company
  • 3:45 PM – 4:30 PM ET
    Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs
  • 3:45 PM – 4:30 PM ET
    Unveiling the Impact of Radiation Therapy: Navigating Acute and Long-Term Side Effects for Optimal Patient Care
  • 3:45 PM – 4:45 PM ET
    Oral Poster Presentations
  • 4:45 PM – 5:30 PM ET
    Independent Certified Satellite Symposium Targeted Therapy Approaches for Metastatic Urothelial Carcinoma
  • 5:30 PM – 6:15 PM ET
    Independent Certified Satellite Symposium Treatment Advances with Novel Anti-Androgen Therapy, PARP Inhibitors, and NGI For Hormone-Sensitive and Castration-Resistant Prostate Cancer
  • 6:15 PM – 8:15 PM ET
    Independent CE-Accredited Dinner Satellite Symposium
    Advancing the Myelofibrosis Treatment Paradigm: A Case-Based Collaborative for the Advanced Practitioner in Oncology